Clinical Trial Update: Comparison of Acoustic Attenuation Parameter Using FibroTouch With Liver Biopsy for Diagnosis of Hepatic Steatosis

View source ↗

Summary

A clinical trial update evaluating whether the Acoustic Attenuation Parameter from FibroTouch can diagnose hepatic steatosis as an alternative to liver biopsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: Wuxi Hisky Medical Technology Co Ltd | Conditions: Fatty Liver, Hepatic Steatosis | Status: UNKNOWN